| abstract |
This invention concerns HIV replication inhibitors of formula n nthe N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, provided that when Q is halo then Z is N; or when Q is polyhaloC 1-6 alkyl then Y is hydrogen or C 1-6 alkyl; their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them. |